ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 744075 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 744075; 2) Community: the network communities that were significantly associated with the response to NSC 744075; 3) Molecule: the relationships between components within communities and NSC 744075; 4) MDR: the compounds that were significantly associated with the NSC 744075.

NSC Compound Enrichment Correlation
NSC 744912 GX15-070 0.0194362855512953 0.47315818
NSC 753665 Null 0.0194362855512953 0.49846118
NSC 758539 Null 0.0194362855512953 0.35557592
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0208632511155816 0.36479624
NSC 747174 Null 0.0208632511155816 0.51494464
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.0208632511155816 0.44677433
NSC 758664 Sirolimus [USAN] 0.0208632511155816 -0.13060302
NSC 758682 ARTENIMOL 0.0208632511155816 0.67736768
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0208632511155817 0.38874059
NSC 135929 Null 0.0208632511155817 0.60497567
Total:153  Current:82    [First] [Prev] [Next] [Last]